Hodgkin's lymphoma Posts on Medivizor
Navigation Menu

Hodgkin’s lymphoma Posts on Medivizor

Does bone Hodgkin lymphoma affect survival in patients with Hodgkin lymphoma?

Posted by on Feb 19, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated if patients with Hodgkin lymphoma (HL) found in the bones have worse outcomes than patients with HL in the lymph nodes. It was found that having bone HL did not reduce survival of patients. Some background Many patients with HL are cured by treatment. After 5 years, almost 86% of patients survive. When...

Read More

Evaluating A+AVD for patients with newly diagnosed advanced Hodgkin lymphoma

Posted by on Feb 17, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of brentuximab vedotin (Adcetris) plus chemotherapy for patients with advanced (stage 3 – 4) Hodgkin’s lymphoma (HL). This study concluded that this treatment is effective for these patients. Some background The most commonly used frontline chemotherapy regimen for advanced HL...

Read More

Oncolytic Virus Treatments

Oncolytic Virus Treatments

Posted by on Feb 10, 2019 in Blog, Breast cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Prostate cancer | 0 comments

In 1904, a physician wrote about a patient with leukemia who went into remission when he got the flu. Though the patient was not cured, it was a ray of hope at a time when there were no treatments for leukemia. Other cases were reported throughout the years of people with Burkitt’s Lymphoma and Hodgkin’s Lymphoma going into remission when they...

Read More

Is BRESHAP an effective treatment for relapsed and unresponsive Hodgkin lymphoma?

Posted by on Feb 8, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined how safe and effective brentuximab vedotin (Adcedris) is when added to conventional treatments for relapsed and unresponsive Hodgkin lymphoma.  This study concluded that this treatment is safe and effective when used as part of the treatment for Hodgkin lymphoma. Some background Standard treatment for...

Read More

ASCO’s National Cancer Opinion Survey Results

ASCO’s National Cancer Opinion Survey Results

Posted by on Jan 24, 2019 in Blog, Breast cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 0 comments

During July and early August of  2018, the Harris Poll in association with the American Society of Clinical Oncologists (ASCO’s) conducted a poll of 4,887 U.S. adults, 1001 of these have or had cancer. This second annual National Cancer Opinion Survey explored a wide range of topics. The findings clearly describe disparities in the care patients with...

Read More

A review of adolescent Hodgkin lymphoma.

Posted by on Jan 24, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study reviewed how the research on pediatric and adult Hodgkin lymphoma (HL) could be applied to adolescent HL. The main finding was that treatments for pediatric and adult HL have similar effects in adolescent HL. Some background About 8500 people are diagnosed with HL in the US each year. There are 2 main types of HL:...

Read More

Evaluating BEAM conditioning for allogeneic stem cell transplantation in patients with relapsed or unresponsive lymphoma

Posted by on Jan 17, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the effectiveness and safety of BEAM (carmustine, etoposide, cytarabine, and melphalan) chemotherapy before allogeneic hematopoietic cell transplantation (alloHCT; transferring healthy cells from a donor) for relapsed or unresponsive lymphoma. This study concluded that alloHCT with BEAM chemotherapy is an alternative...

Read More

What are the effects of lenalidomide, doxorubicin, vinblastine and dacarbazine in Hodgkin lymphoma?

Posted by on Jan 12, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated the effects of adding lenalidomide (Revlimid) to doxorubicin (Adriamycin), vinblastine (Velban), and dacarbazine (DTIC-Dome) treatment for older patients with Hodgkin lymphoma (HL). The main finding was that this combination is effective but severe side-effects may be experienced. Some background HL is a cancer...

Read More

Does PET/CT scanning affect treatment and survival of patients with lymphoma?

Posted by on Dec 30, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined the effect of PET/CT scanning on the treatment and survival of patients with lymphoma. Researchers found that PET/CT improved the management plan and survival of these patients. Some background PET/CT are types of scans that detect changes in cells and tissues inside the body. They can be used to check the sites of...

Read More